申请人:Taniguchi Nobuaki
公开号:US20080214543A1
公开(公告)日:2008-09-04
The present invention relates to a novel N-phenyl-(2R,5S)dimethylpiperazine derivatives useful as antiandrogenic agent which exhibits a sufficient prostate gland reducing effect as compared with conventional compounds and are excellent in oral activity. The compound of the present application is useful in preventing or treating prostate cancer, benign prostatic hyperplasia, and the like. The present invention also provides a novel intermediate useful in producing the compound of the present invention.
本发明涉及一种新型N-苯基-(2R,5S)二甲基哌嗪衍生物,其作为抗雄激素剂具有足够的前列腺减少效果,与传统化合物相比具有出色的口服活性。本申请的化合物在预防或治疗前列腺癌、良性前列腺增生等方面具有用途。本发明还提供了一种新型中间体,用于制备本发明的化合物。